Erasmus University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2024

  1. Lipid-based nanosystems: the next generation of cancer immune therapy

    Journal of Hematology and Oncology, Vol. 17, Núm. 1

2022

  1. Stealth nanoparticles in oncology: Facing the PEG dilemma

    Journal of Controlled Release, Vol. 351, pp. 22-36

2021

  1. Drug transport kinetics of intravascular triggered drug delivery systems

    Communications Biology, Vol. 4, Núm. 1

  2. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

2020

  1. Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society

    Frontiers in Endocrinology, Vol. 11

  2. Sensitization of drug resistant sarcoma tumors by membrane modulation: Via short chain sphingolipid-containing nanoparticles

    Nanoscale, Vol. 12, Núm. 32, pp. 16967-16979

2019

  1. A new immune-nanoplatform for promoting adaptive antitumor immune response

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 13-25

  2. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response

    International Journal of Nanomedicine, Vol. 14, pp. 2069-2089

2018

  1. Body mass index is negatively associated with telomere length: A collaborative cross-sectional meta-analysis of 87 observational studies

    American Journal of Clinical Nutrition, Vol. 108, Núm. 3, pp. 453-475

  2. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes

    Cellular and Molecular Immunology, Vol. 15, Núm. 2, pp. 158-170

2017

  1. Cell membrane modulation as adjuvant in cancer therapy

    Cancer Treatment Reviews, Vol. 52, pp. 48-57

2016

  1. EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model

    Nanomedicine, Vol. 11, Núm. 5, pp. 465-477

  2. Targeting melanoma with immunoliposomes coupled to anti-MAGEAI TCR-like single-chain antibody

    International Journal of Nanomedicine, Vol. 11, pp. 955-975

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 11, Núm. 6, pp. 921-936